SCHEMBL16587742

SCHEMBL16587742

Cc1ccc(N2CCC(C(C)C)C(C)(C)C2)nc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 2/20 0.45
HRH3 Q9Y5N1 1/20 0.44
GRIN2D O15399 1/20 0.41
GRIN3B O60391 1/20 0.41
GRIN1 Q05586 1/20 0.41
GRIN2A Q12879 1/20 0.41
GRIN2B Q13224 1/20 0.41
GRIN2C Q14957 1/20 0.41
GRIN3A Q8TCU5 1/20 0.41
PDE10A Q9Y233 1/20 0.39
OGA O60502 1/20 0.38
PANK3 Q9H999 1/20 0.38
MAPT P10636 1/20 0.36
TACR3 P29371 1/20 0.36
LCAT P04180 1/20 0.36
CCNA2 P20248 1/20 0.36
CDK2 P24941 1/20 0.36
CDK5 Q00535 1/20 0.36
CDK5R1 Q15078 1/20 0.36
P2RX3 P56373 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16472415 1.00 GPR119 (0.45) GPR119HRH3GRIN2DGRIN3BGRIN1
SCHEMBL16472413 0.83 KCNH2 (0.40) GPR119HRH3MAPTPTGES
SCHEMBL16587722 0.83 KCNH2 (0.40) GPR119HRH3MAPTPTGES
SCHEMBL16587751 0.83 GPR119 (0.42) GPR119HRH3OGADHFRSMO
SCHEMBL16472271 0.83 GPR119 (0.42) GPR119HRH3OGADHFRSMO
SCHEMBL16587752 0.81 OGA (0.38) HRH3OGAPTGES
SCHEMBL16472266 0.81 OGA (0.38) HRH3OGAPTGES
SCHEMBL16587747 0.79 ADRB1 (0.39) GPR119MAPT
SCHEMBL16472342 0.79 ADRB1 (0.39) GPR119MAPT
SCHEMBL16472287 0.78 GPR119 (0.43) GPR119HRH3GRIN2DGRIN3BGRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8987268-B2 Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases BRISTOL-MYERS SQUIBB COMPANY (US) 2015-03-24 US disclosed